deltatrials
Completed NA INTERVENTIONAL 3-arm NCT04879810

Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease

Pilot Clinical Trial Investigating the Ability of Plant Exosomes +/- Curcumin to Abrogate Symptoms of Inflammatory Bowel Disease (IBD)

Sponsor: University of Louisville

Updated 5 times since 2021 Last updated: Nov 2, 2022 Started: Mar 1, 2018 Primary completion: Aug 2, 2022 Completion: Aug 2, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Irritable Bowel Disease, this trial is completed. The trial is conducted by University of Louisville and has accumulated 5 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jun 2021 – ~Feb 2022 · 8 months · monthly snapshotRecruiting~Feb 2022 – ~Dec 2022 · 10 months · monthly snapshotRecruiting~Dec 2022 – ~Jul 2024 · 19 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Dec 2022 — Jul 2024 [monthly]

    Completed NA

    Status: RecruitingCompleted

  4. Feb 2022 — Dec 2022 [monthly]

    Recruiting NA

  5. Jun 2021 — Feb 2022 [monthly]

    Recruiting NA

    First recorded

Mar 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Louisville
Data source: University of Louisville

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations